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Predictive Factors of the Outcome of Extracorporeal Shockwave 
Lithotripsy for Ureteral Stones
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Department of Urology, Yeungnam University College of Medicine, Daegu, Korea
Purpose: Extracorporeal Shock Wave Lithotripsy (ESWL) has shown successful out-
comes for ureteral stones. We investigated predictive factors for failure of ESWL for 
treating ureteral stones.
Materials and Methods: A total of 153 patients who underwent ESWL between July 
2006 and July 2009 for ureteral stones diagnosed by non-enhanced spiral computed 
tomography were divided into two groups: (group A, stone size ≤10 mm; and group B, 
stone size ＞10 mm). The failure was defined as remnant stones ＞4 mm. We assessed 
age, sex, body mass index, stone size, laterality, location, skin-to-stone distance (SSD), 
Hounsfield unit, and the presence of secondary signs (hydronephrosis, renal enlarge-
ment, perinephric fat stranding, and tissue rim sign). We analyzed predictive factors 
by using logistic regression in each group.
Results: The success rates were 90.2% and 68.6% in group A and B, respectively. In 
the univariate analysis of each group, stone size, SSD, and all secondary signs showed 
statistically significant differences in terms of the outcome of ESWL (p＜0.05). In the 
multivariate logistic regression, stone size (odds ratio [OR], 50.005; 95% confidence in-
terval [CI], 6.207 to 402.852) was an independent predictive factor in group A. The pres-
ence of perinephric fat standing (OR, 77.634; 95% CI, 1.349 to 446.558) and stone size 
(OR, 19.718; 95% CI, 1.600 to 243.005) were independent predictive factors in group 
B.
Conclusions: Stone size is an independent predictive factor influencing failure of ESWL 
for treating ureteral stones. In larger ureteral stones (＞10 mm), the presence of peri-
nephric fat stranding is also an independent predictive factor.
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INTRODUCTION
Extracorporeal shockwave lithotripsy (ESWL) has been 
considered as a first-line treatment for ureteral stones for 
the past 20 years [1]. The success rate of ESWL in the treat-
ment of ureteral stones is about 80 to 90% [2]. Some pa-
tients whose stones may not be fragmented by repeated 
ESWL will require other surgical interventions. Failure of 
ESWL is more common with ureteral stones larger than 10 
mm [3]. The success rate is influenced by stone factors 
(stone size, location, composition, degree of obstruction), 
clinical factors (symptom severity, patient’s expectations, 
associated infection, solitary kidney, abnormal ureteral 
anatomy), and technical factors (available equipment, 
cost) [4]. However, it is not certain which factors influence 
the outcome of ESWL [5-8].
Recently, several studies have reported the incidence of 
secondary signs and their influence in ESWL treatment 
[9-12]. However, whether secondary signs affect the out-
come in ESWL treatment remains controversial. Thus, we 
investigated the predictive factors of ESWL outcome, in-
cluding secondary signs, in the treatment of ureteral 
stones.Korean J Urol 2012;53:424-430
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TABLE 1. Baseline clinical and radiologic characteristics
Characteristic
Group A 
(stone size ≤10 mm)
Group B
(stone size ＞10 mm)
No. of patients
Age (yr)
Sex
Male
Female 
Laterality
Right
Left 
BMI (kg/m
2)
Stone size (mm)
Stone location 
Upper
Middle
Lower
SSD (mm)
Hounsfield unit
Secondary signs
Hydronephrosis 
Absent
Present
Renal enlargement
Absent
Present
Perinephric fat 
stranding 
Absent
Present
Tissue rim sign 
Absent
Present
102
  54.5±11.78 
(34-74)
59 (57.9)
43 (42.1)
52 (51.0)
50 (49.0)
23.4±2.47
  6.1±1.36 
  (4.1-10.0)
69 (67.7)
12 (11.8)
21 (20.5)
103.2±12.60
  756.5±154.68
35 (34.3)
67 (65.7)
54 (53.0)
48 (47.0)
43 (42.2)
59 (57.8)
34 (33.3)
68 (66.7)
51
  55.5±13.28 
(32-79)
31 (60.8)
20 (39.2)
26 (51.0)
25 (49.0)
23.8±2.85
14.3±4.65 
(10.1-22.0)
34 (66.7)
  6 (11.7)
11 (21.6)
101.0±13.71
833.8±75.46
  9 (17.6)
42 (82.4)
24 (47.1)
27 (52.9)
18 (35.3)
33 (64.7)
24 (45.1)
27 (52.9)
Values are presented as mean±SD (range), number (%) or 
mean±SD.
BMI, body mass index; SSD, skin-to-stone distance.
FIG. 1. The non-enhanced computed tomography scan images of secondary signs. (A) Hydronephrosis of the right kidney. (B) Renal 
enlargement and perinephric fat stranding of the left kidney (arrowhead). (C) Tissue rim sign of the left ureter (arrow).
MATERIALS AND METHODS
A total of 153 patients who underwent ESWL between July 
2006 and July 2009 for ureteral stones that were diagnosed 
by non-enhanced spiral computed tomography (NESCT) 
were included in this retrospective study. The inclusion cri-
teria were stone size ＞4 mm and stones that were solitary 
and radiopaque on the pretreatment plain radiography. 
Patients with urinary tract infections, blood coagulation 
disorders, ureteral stricture, neurogenic bladder, or poly-
cystic kidney were excluded. We divided the patients into 
two groups (group A, stone size ≤10 mm; group B, stone 
size ＞10 mm) and assessed age, sex, body mass index 
(BMI), stone size, laterality, location, skin-to-stone dis-
tance (SSD), Hounsfield unit (HU), and presence of secon-
dary signs (hydronephrosis, renal enlargement, peri-
nephric fat stranding, and tissue rim sign) in each group 
(Table 1). 
The BMI was measured for each patient by dividing the 
patient’s weight in kilograms by height in meters squared. 
The SSD was measured on NESCT by three distances from 
the stone to the skin (0
o, 45
o, and 90
o). The average SSD was 
measured from these values and was recorded as the repre-
sentative SSD for each stone. The HU for each stone was 
determined on the pretreatment NESCT. Non-enhanced 
helical images were obtained by using a 5-mm collimation 
width from the top of the kidneys to the level of the pubic 
symphysis. Three regions of interest (ROI) were analyzed 
in the images showing the stones in the largest dimension. 
All measurements were made with a similar-sized ROI 
(2.0±0.5 mm
2). The HU average of three ROIs represented 
the HU for that stone. Secondary signs included the pres-
ence or absence of hydronephrosis, renal enlargement, per-
inephric fat stranding, and tissue rim sign (Fig. 1). 
Hydronephrosis was distinguished by visualization of the 
dilated renal pelvocaliceal system. Renal enlargement was 
detected as an increase in the thickness of the renal paren-
chyma or an increase in the length of the kidney in acute 
obstruction. Perinephric fat stranding was defined as the 
stranding of adipose tissue around the kidney. Tissue rim 
sign was recognized as the observation of the annular soft 
tissue caused by edematous ureteral wall surrounding the 
stones [13]. All radiologic factors were reviewed by one spe-Korean J Urol 2012;53:424-430
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TABLE 2. Outcomes of ESWL for ureteral stones according to the number of sessions
Session Success Incomplete Failure Auxiliary  procedures  (n=26)
1st (n=153) 101 (66.0) 31 (20.3) 21 (13.7) URS (20) / open ureterolithotomy (1)
2nd (n=31)   22 (14.4)   7 (4.6)   2 (1.3) URS (1) / ESWL (1
a)
3rd (n=8)     4 (2.6)   2 (1.3)   2 (1.3) URS (2)
4-8th (n=2)     0 (0)   0 (0)   2 (1.3) URS (2)
Values are presented as number (%).
ESWL, extracorporeal shockwave lithotripsy; URS, ureteroscopic removal of stone.
a:This patient was recommended to undergo URS but underwent a 3rd session of ESWL. After failure of the 3rd session, URS was 
performed.
cialized uroradiologist.
ESWL was performed by using an electroconductive lith-
otriptor (Sonolith Praktis, EDAP TMS, Vaulx-en-Velin, 
France). The generator power was started at 60% and in-
creased stepwise to 100%. A maximum of 3,000 shock-
waves (range, 1,500 to 3,000; median, 2,500) were delivered 
to a maximal power of 20 to 24 kV at 120 shocks/min during 
one session. The stones were fragmented under fluoro-
scopic guidance, and the number of shockwaves and energy 
level were recorded. The result of treatment was evaluated 
by plain radiography at 1 or 2 weeks after each ESWL. 
When there was a large fragment with a long diameter ＞4 
mm, ESWL was tried repeatedly until each fragment be-
came smaller than 4 mm. The failure of ESWL was defined 
as remnant stones larger than 4 mm at 3 months after the 
first session.
The data were analyzed to identify clinical and radiologic 
factors associated with treatment failure. Univariate anal-
ysis was used to individually assess the association be-
tween the various factors and outcomes. Thereafter, the 
significantly associated variables were tested with multi-
variate logistic regression analysis to identify the in-
dependent predictors of treatment failure. Statistical anal-
ysis was performed by using SPSS ver. 12.0 (SPSS Inc., 
Chicago, IL, USA). Values of p＜0.05 were considered stat-
istically significant.
RESULTS
A total of 153 patients with ureteral stones were analyzed. 
The patients’ mean age was 54.5±11.78 years (range, 34 to 
74 years) in group A and 55.5±13.28 years (range, 32 to 79 
years) in group B. The mean stone size was 6.1±1.36 mm 
(range, 4.1 to 10.0 mm) and 14.3±4.65 mm (range, 10.1 to 
22.0 mm) in each group. The success rate was 90.2% and 
68.6%, respectively (Table 1).
The overall success rate was 83.0% (n=127) and the fail-
ure rate was 17.0% (n=26). Patients in whom ESWL failed 
underwent auxiliary procedures. Twenty-five patients 
with remnants after ESWL underwent ureteroscopic re-
moval of stone and 1 patient underwent open ureter-
olithotomy (Table 2). We observed a complication rate of 
3.2% (n=5), including acute pyelonephritis (n=3, 1.9%) that 
was successfully treated by percutaneous nephrostomy 
catheterization with antibiotics and a subcapsular hema-
toma (n=2, 1.3%) that resolved spontaneously. A static 
steinstrasse was observed in 3 patients and analgesics 
were required in 5 patients for 1 day for post-ESWL pain.
In the univariate analysis, age, sex, BMI, laterality, loca-
tion, and HU were not significantly different in terms of 
outcome of ESWL (Table 3). The mean stone size in the suc-
cess and failure groups, respectively, was 5.9±1.27 mm vs. 
7.5±1.43 mm in group A (p＜0.001) and 12.2±2.15 mm vs. 
19.1±4.15 mm in group B (p＜0.001). The mean SSD in the 
success and failure groups, respectively, was 102.4±12.88 
mm vs. 110.8±5.66 mm in group A (p=0.043) and 
97.8±12.97 mm vs. 107.9±13.02 mm in group B (p=0.013) 
(Table 3). All the secondary signs showed statistically sig-
nificant differences in terms of outcome of ESWL (Table 3). 
In the multivariate logistic regression, stone size (odds 
ratio [OR], 50.005; 95% confidence interval [CI], 6.207 to 
402.852) was an independent predictive factor for failure 
of ESWL in group A. Perinephric fat standing (OR, 77.634; 
95% CI, 1.349 to 446.558) and stone size (OR, 19.718; 95% 
CI, 1.600 to 243.005) were independent predictive factors 
in group B (Table 4).
DISCUSSION
Since its introduction in the early 1980s, ESWL has become 
a safe and accepted treatment modality for ureteral stones 
[1]. The success rate of ESWL in the treatment of ureteral 
stones is about 80 to 90% [2]. Many studies have demon-
strated that the consistency, size, shape, location, and HU 
of ureteral stones and BMI may be predictors of the out-
come of ESWL [4-8].
Concerning stone size, a larger size is associated with a 
higher risk for failure of treatment of urinary tract stones. 
Recent studies have shown that stone size is an indepen-
dent predictor of the stone-free rate after ESWL [14-17]. 
It has been reported that patients with stones ＞10 mm 
more frequently fail to be rendered stone-free by ESWL 
[18]. In the 2007 American Urological Association/Euro-
pean Association of Urology guideline, ureteral stones 
were classified as either less than or greater than 10 mm. 
At all locations in the ureter, the treatment outcome for Korean J Urol 2012;53:424-430
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TABLE 3. Univariate analysis of outcomes of ESWL for ureteral stones
Group A (stone size ≤10 mm) Group B (stone size >10 mm)
Success Failure p-value Success Failure p-value
No. of patients (%) 92 (90.2) 10 (9.8) 35 (68.6) 16 (31.4)
Age (yr)   53.8±11.88 60.8±8.88 0.073
a   54.6±14.17   56.7±11.40 0.673
a
Sex   1.000
c   0.654
b
    Male 53 (52.0)   6 (5.9) 22 (43.2)   9 (17.6)
    Female 39 (38.2)   4 (3.9) 13 (25.5)   7 (13.7)
Laterality 1.000
c 0.925
b
    Right 47 (46.1)   5 (4.9) 18 (35.3)   8 (15.7)
    Left 45 (44.1)   5 (4.9) 17 (33.3)   8 (15.7)
BMI (kg/m
2) 23.4±2.44 23.1±2.79 0.734
a 24.1±3.13 23.3±2.13 0.395
a
Stone size (mm)   5.9±1.27   7.5±1.43  ＜0.001
a 12.2±2.15 19.1±4.15    ＜0.001
a
Location 0.980
c 0.496
c
    Upper 62 (60.8)   7 (6.9) 25 (49.1)   9 (17.6)
    Middle 11 (10.8)   1 (1.0) 4 (7.8) 2 (3.9)
    Lower 19 (18.5)   2 (2.0)   6 (11.8) 5 (9.8)
SSD (mm) 102.4±12.88   110.8±5.66 0.043
a   97.8±12.97 107.9±13.02 0.013
a
Hounsfield unit    781.1±157.22   829.3±126.56 0.612
a 814.2±78.83 844.4±68.32 0.538
a
Secondary signs
    Hydronephrosis  0.014
c 0.043
c
        Absent 35 (34.3)   0 (0.0)   9 (17.6) 0 (0.0)
        Present 57 (55.9) 10 (9.8) 26 (51.0) 16 (31.4)
    Renal enlargement  0.043
c 0.006
b
        Absent 52 (51.0)   2 (2.0) 21 (41.2) 3 (5.9)
        Present 40 (39.2)   8 (7.8) 14 (27.5) 13 (25.4)
    Perinephric fat stranding                                                              0.005
c                                                                             0.021
b
        Absent 43 (42.2)   0 (0.0) 16 (31.4) 2 (3.9)
        Present 49 (48.0) 10 (9.8) 19 (37.2) 14 (27.5)
    Tissue rim sign  0.028
c 0.001
b
        Absent 34 (33.3)   0 (0.0) 22 (41.2) 2 (3.9)
        Present 58 (56.9) 10 (9.8) 13 (25.4) 14 (27.5)
Values are presented as mean±SD or number (%).
ESWL, extracorporeal shockwave lithotripsy; BMI, body mass index; SSD, skin-to-stone distance.
a:Student’s t-test, 
b:Pearson chi-square test, 
c:Fisher’s exact test.
stones less than 10 mm was superior to that for stones 
greater than 10 mm [4]. Specifically, for stones in the distal 
ureter, the stone-free rate for stones less than 10 mm treat-
ed by SWL was 86%, compared with a 74% stone-free rate 
for those greater than 10 mm [4]. In our series, we divided 
the patients into two groups and evaluated their outcomes 
and predictive factors. The success rates were 90.2% in the 
group with a stone size ≤10 mm (group A) and 68.6% in 
the group with a stone size ＞10 mm (group B). The multi-
variate analysis revealed that stone size was an in-
dependent predictor of failure of ESWL in each group.
A positive correlation exists between SSD and BMI when 
examining all upper tract stones. BMI and SSD are cer-
tainly interrelated, but body fat distribution varies be-
tween by gender and race [19] and cannot be reliably used 
as a surrogate marker for SSD. The utility of BMI in pre-
dicting successful ESWL is variable. For example, Pareek 
et al. [8] found BMI to be a significant predictor of success. 
Conversely, in another study, BMI failed to predict success-
ful ESWL outcomes, whereas SSD remained a significant 
predictor [20]. In our series, BMI was not a significant pre-
dictor of failure of ESWL. We suggest that the effect of BMI 
is probably related to the distance of the stone from the skin, 
which reflects the shockwave path in the body. BMI may 
not truly reflect central body fat distribution, which is prob-
ably the main factor affecting SSD. Therefore, SSD is prob-
ably a more direct measurement of the effect of body build 
on ESWL outcome than is BMI.
Many investigators have reported that SSD is a sig-
nificant predictor in ureteral stones. Wiesenthal et al. [21] 
suggested that SSD was a significant predictor of litho-
tripsy success for ureteral stones. In the multivariate anal-
ysis, SSD ＞110 mm (OR, 0.49; 95% CI, 0.31 to 0.78) was 
a significant predictor of outcome. Perks et al. [22] also sup-
ported this finding. They reported that SSD of ＜9 cm (OR: 
2.8; 95% CI: 1.1-7.2) can predict SWL success. In our series, 
SSD was a significant predictor of treatment outcome in the 
univariate analysis (＜1.0 cm group, p=0.043; ＞1.0 cm 
group, p=0.013), but was not a significant predictor in the 
multivariate analysis (＜1.0 cm group, p=0.082; ＞1.0 cm Korean J Urol 2012;53:424-430
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TABLE 4. Multivariate analysis of predictive factors for failure of ESWL
Group A (stone size ≤10 mm) Group B (stone size >10 mm)
OR (95% CI) p-value OR (95% CI) p-value
Stone size   50.005 (6.207-402.852) 0.013   19.718 (1.600-243.005) 0.020
SSD 1.064 (0.991-1.141) 0.082 1.062 (1.014-1.111) 0.110
Hydronephrosis   1.088 (0.139-84.640) 0.404   2.714 (0.221-33.356) 0.435
Renal enlargement   1.720 (0.176-16.822) 0.641 0.043 (0.002-1.182) 0.063
Perinephric fat stranding   3.276 (0.460-30.191) 0.083   77.634 (1.349-446.558) 0.035
Tissue rim sign 1.068 (0.987-1.157) 0.104 0.091 (0.006-1.401) 0.086
ESWL, extracorporeal shockwave lithotripsy; SSD, skin-to-stone distance.
group, p=0.110). We may not have had enough data to dis-
tinguish the body fat distribution (range, 81.4 to 124.1 
mm), and additional evidence from larger trials may reveal 
the importance of SSD in the management of ureteral 
stones.
The attenuation value of ureteral stones on axial com-
puted tomography images has been studied as a predictor 
of fragmentation efficiency [8]. However, because these 
values differ according to the size of the ROI and portion 
in the same stone, the use of these values in the manage-
ment of ureteral stones is still problematic. In our series, 
HU was not a significant predictor in the univariate analy-
sis (p＞0.05). We suggest that the small sample size and 
short range of HU (n=153, 617.2 to 982.5 HU) may have pre-
vented accurate statistical comparison of the stone compo-
sition with the attenuation value.
A correlation between stone attenuation and stone fra-
gility was first demonstrated in vitro. As the attenuation 
value of calcium stones increases, a greater number of 
shockwaves are needed for fragmentation [23]. Likewise, 
in a clinical retrospective review, patients with calculi ＞
750 HU were 10.5 times as likely to need ≥3 SWL sessions 
as were those with calculi of ≤750 HU [24]. Joseph et al. 
[7] reported a 95% success rate for calculi ＜1,000 HU vs. 
55% for stones ＞1,000 HU (p＜0.01). Several investigators 
have since shown that ESWL is more likely to fail for pa-
tients with renal calculi ＞750 to 1,000 HU and these pa-
tients should be considered for other treatment modalities 
[6-8,24].
Whether secondary signs in patients with ureteral 
stones affect outcome in ESWL treatment remains con-
troversial. Ege et al. [25] reported the incidence of secon-
dary signs and their influence on patient management. 
The most reliable signs indicating necessary endoscopic 
removal or lithotripsy were hydroureter, hydroneph-
rosis, periureteral edema, and unilateral renal enlar-
gement.
On the other hand, Boulay et al. [26] evaluated 99 pa-
tients and retrospectively analyzed the presence, size, and 
location of ureteral stones and the presence and severity 
of secondary signs of obstruction. A significant difference 
in stone size was found between patients who were treated 
conservatively and those who underwent a urological pro-
cedure (3.3±1.3 mm vs. 7.0±6.2 mm, p＜0.1). The presence 
and severity of secondary signs of obstruction were not sig-
nificantly different between the two groups and did not af-
fect treatment. Those authors concluded that stone size 
alone correlated with the patient’s treatment and outcome. 
In another study, Seitz et al. [27] reported secondary signs 
before laser ureterolithotripsy preoperatively did not cor-
relate these with stone-free rates. The presence of secon-
dary signs (renal enlargement, perinephric stranding, ure-
teral dilation, ureteral rim sign) could not predict intra-
operatively verified stone impaction or stone-free rates.
Perinephric fat stranding is defined as linear areas of soft 
tissue attenuation in the perinephric space, which can re-
sult from any acute process or injury to the kidney. The 
changes in the perinephric space in the presence of urinary 
stones are thought to result from adaptation of the kidney 
to obstruction. Immediately after acute ureteral ob-
struction, the intraluminal pressure of the collecting sys-
tem increases and reaches 3 to 5 times normal pressure 
[13]. The escape of urine into the renal interstitium 
(pyelotubular backflow), across the renal pelvis into the re-
nal sinus (pyelosinus backflow), or into the lymphatic sys-
tem (pyelolymphatic backflow) or the renal venous system 
(pyelovenous backflow) plays important roles in decom-
pression of the intraluminal pressure [28]. As proposed by 
Kunin [29], lymphatic flow in the perinephric space results 
from elevated intrarenal venous pressure, and venous sta-
sis, pyelosinus, and pyelovenous backflow may contribute 
to perinephric stranding [28]. Unilateral perinephric 
stranding is probably the manifestation of increased pres-
sure in the collecting system in the early phase of ureteral 
obstruction. In our series, perinephric fat stranding was an 
independent predictor in group B (stone size ＞10 mm). 
Other secondary signs were not significant. All of the secon-
dary signs are caused by ureteral obstruction; however, not 
all of these represent the degree of ureteral obstruction. We 
suggest that the perinephric fat stranding reflects a con-
dition to maintain the balance between pressure in the col-
lecting system and ureteral wall resistance around the 
stones. Despite increased pressure in the collecting sys-
tem, the degree of obstruction was too severe in group B. 
In this condition, the outcomes of ESWL were probably less 
successful than in the group without perinephric fat Korean J Urol 2012;53:424-430
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stranding. Although the mechanism of perinephric fat 
stranding may be similar in patients with smaller stone 
sizes, perinephric fat stranding was not significant in 
group A. We speculate that the obstruction is more easily 
resolved in patients with smaller stone sizes. Thus, peri-
nephric fat stranding may be a secondary sign that more 
readily reflects the degree of ureteral obstruction in the 
case of large stones.
CONCLUSIONS
Stone size is an independent predictive factor influencing 
failure of ESWL in the treatment of ureteral stones. In ad-
dition to stone size, the presence of perinephric fat strand-
ing is also an independent predictive factor for larger ure-
teral stones (＞10 mm).
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